Dannex Ayrton Starwin Plc

Equities

DASPHARMA

GHEDASP58306

End-of-day quote Ghana S.E. Other stock markets 03:30:00 19/06/2024 am IST			5-day change	1st Jan Change
0.38 ^GHS	0.00%		0.00%	-5.00%

2021	Dannex Ayrton Starwin Plc Announces Unaudited Earnings Results for the Period Ended March 31, 2021	CI
2021	Dannex Ayrton Starwin Plc Reports Unaudited Earnings Results for the Year Ended December 31, 2020	CI

Dannex Ayrton Starwin : PR-175 DANNEX AYRTON STARWIN PLC NOTICE OF 4TH ANNUAL GENERAL MEETING

June 13, 2024 at 10:39 pm IST

PR 175 DANNEX AYRTON STARWIN PLC NOTICE OF 4TH ANNUAL GENERAL MEETING (1)

PR 175 DANNEX AYRTON STARWIN PLC NOTICE OF 4TH ANNUAL GENERAL MEETING (2)

Attachments

Original Link
Permalink

Disclaimer

Dannex Ayrton Starwin plc published this content on 13 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 June 2024 17:08:05 UTC.

Latest news about Dannex Ayrton Starwin Plc

Dannex Ayrton Starwin Plc Announces Unaudited Earnings Results for the Period Ended March 31, 2021	01/21/01	CI
Dannex Ayrton Starwin Plc Reports Unaudited Earnings Results for the Year Ended December 31, 2020	04/21/04	CI
Dannex Limited completed the acquisition of remaining unknown minority stake in Starwin Products Company Limited/Ayrton Drug Manufacturing Ltd.	08/20/08	CI
Dannex Limited agreed to acquire remaining unknown minority stake in Starwin Products Company Limited/Ayrton Drug Manufacturing Ltd.	19/18/19	CI
Dannex Limited completed the acquisition of 53.47% stake in Ayrton Drugs Manufacturing Company Ltd. from Adcock Ingram Holdings Limited.	02/16/02	CI
Dannex Limited entered into a sale of shares agreement to acquire 53.47% stake in Ayrton Drugs Manufacturing Company Ltd. from Adcock Ingram Holdings Limited.	26/16/26	CI

Chart Dannex Ayrton Starwin Plc

Duration

Period

More charts

Company Profile

Dannex Ayrton Starwin Plc specialises in the manufacture and distribution of pharmaceutical products.

Sector

More about the company